The role of histamine in the acute inflammatory responses to intradermal platelet activating factor.
- 26 July 1991
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 32 (1) , 85-90
- https://doi.org/10.1111/j.1365-2125.1991.tb05617.x
Abstract
1. The role of histamine in PAF‐induced acute inflammatory responses (flare and weal) in the skin has been evaluated in a series of three separate studies. 2. Terfenadine, a potent H1‐selective histamine antagonist virtually abolished the flare response and significantly inhibited the weal response. 3. Histamine depletion in the skin using compound 48/80 resulted in similar effects on the flare and weal response. Two consecutive daily injections of compound 48/80 were found to deplete comprehensively skin sites of histamine and the ability of skin to respond to PAF was completely restored within 2 weeks of compound 48/80 treatment. 4. Intradermally injected PAF was associated with acute rises in plasma histamine in blood drawn from a draining vein with peak concentrations occurring within 5 min of injection. 5. No difference in PAF‐induced flare and weal response was found between atopic and non‐atopic subjects and this was reflected in the peak plasma histamine results. A significantly higher baseline plasma histamine was found in the atopic group, however, when compared with the non atopic group. 6. It is concluded that histamine has an important role in the acute inflammatory responses to intradermally injected PAF, although there does appear to be a significant direct vascular component in the PAF‐induced weal response.Keywords
This publication has 23 references indexed in Scilit:
- Differential Sensitivities of Purified Human Eosinophils and Neutrophils to Defined ChemotaxinsScandinavian Journal of Immunology, 1989
- Use of plasma histamine levels to monitor cutaneous mast cell degranulationJournal of Allergy and Clinical Immunology, 1989
- Evaluation of a radioimmunoassay for histamine measurement in biologic fluidsJournal of Allergy and Clinical Immunology, 1988
- Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in manJournal of Allergy and Clinical Immunology, 1988
- Skin eosinophilia in atopic patientsJournal of Allergy and Clinical Immunology, 1988
- EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MANThe Lancet, 1986
- Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in mangBritish Journal of Dermatology, 1985
- Inflammatory characteristics of platelet activating factor (PAF-acether) in human skinBritish Journal of Dermatology, 1984
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972
- RELEASE OF VASOACTIVE AMINES FROM RABBIT PLATELETS INDUCED BY SENSITIZED MONONUCLEAR LEUKOCYTES AND ANTIGENThe Journal of Experimental Medicine, 1970